Stock MYCOF MYDECINE INNOVATIONS GROUP INC.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Mydecine Innovations Group Inc.

Equities

MYCOF

CA62849F2008

Delayed OTC Markets
Other stock markets
 11:06:59 29/04/2024 pm IST 		5-day change 1st Jan Change
0.0147 USD -33.45% Intraday chart for Mydecine Innovations Group Inc. +32.43% -1.34%
23/02 Mydecine Innovations Closes Partial Debt Settlement MT
02/02 Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director CI

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Mydecine Innovations Closes Partial Debt Settlement
Mydecine Innovations Group Inc Announces Resignation of Neil Stevenson-Moore as Director
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
Mydecine Innovations Group Inc. Appoints John Ross as Corporate Secretary
Mydecine Innovations Group Appoints Todd Heinzl to the Board of Directors
Mydecine Innovations Group Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
Mydecine Innovations Group Inc. Reports Positive Preclinical Results on the MYCO-006 Series of its Short-Acting Emp Analogues
Mydecine Innovations Group Inc. Auditor Raises 'Going Concern' Doubt
Mydecine Innovations Group Inc. Reports Earnings Results for the Full Year Ended December 31, 2022
Pangenomic Health Inc. completed the acquisition of Mindleap Health Inc. from Mydecine Innovations Group Inc. (OTCPK:MYCO.F).
Mydecine Innovations Group Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Mydecine Innovations Group Inc. Announces Board Changes
Mydecine Innovations Group Inc. Files Full Patent Application Covering MYCO-006 Family of Novel Short-Acting Mdma Analogs
Mydecine Innovations Group Inc. Announces Board Changes
Mydecine Innovations Group Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Mydecine Innovations Group Inc. Announces Resignation of Directors
Mydecine Files Full Patent Application Covering Myco-006 Family of Novel Short-Acting Mdma Analogs
Mydecine Innovations Group Announces U.S. FDA Clears MYCO-001 for Multi-Site Government Funded Trial in Smoking Cessation
Mydecine Innovations Group Inc. Announces Board Changes
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MYCOF Stock
  4. News Mydecine Innovations Group Inc.
  5. Other languages